Thermo Fisher Scientific Influenza A HA Recombinant Rabbit Monoclonal Antibody (2)

Applications and Tested Dilution

Product Specifications

Product Specific Information

This product is preservative free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%–0.1%).

Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning the specific antibody DNA sequences from immunoreactive rabbits, followed by screening individual clones to select optimal candidates for production.

Advantages of recombinant rabbit monoclonal antibodies:

• High specificity and sensitivity
• Lot-to-lot consistency
• Animal origin-free formulations
• Broader immunoreactivity due to the large rabbit immune repertoire

This antibody has specificity for:

• H1N1 (A/California/04/2009) HA
• H1N1 (A/California/07/2009) HA

Target Information

Infectious diseases are a leading cause of death worldwide, including AIDS, tuberculosis, malaria, diarrheal, and respiratory infections, which account for 78% of deaths due to infectious diseases. As some are controlled, new diseases emerge and old ones develop resistance to existing treatments. Many infectious diseases are linked to increased carcinoma risk.

Influenza remains a major research focus due to its genetic variability. Research on SARS and West Nile virus has also increased with infection rates. These antibodies support research by detecting infectious disease agents.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.